Skip to content

Effects of Zinc Supplementation on Anthropometric Factors, Apelin and Inflammatory Markers in Obese Individuals

Effects of Zinc Supplementation on Weight, Body Mass Index (BMI), Waist Circumference, Fat Mass and Lean Mass, Apelin and Inflammatory Markers in Obese Individuals

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02516475
Enrollment
50
Registered
2015-08-06
Start date
2014-10-31
Completion date
2015-06-30
Last updated
2015-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

To study the effects of zinc supplement on anthropometric factors, Apelin and inflammatory markers in obese individuals, 50 obes person who referred to Diet and Nutrition clinic of Shahid Beheshti University of Medical Sciences will be randomly allocated to receive 50 mg zinc capsules or placebos for 15 weeks; both groups will be advised to adherence the investigators' diet . At the first and the end of the intervention,weight, body mass index (BMI), waist circumference, fat mass and lean body mass, concentration of zinc, albumin, hs-CRP, TNF-α and plasma apelin will be assessed and compared between groups.

Interventions

DIETARY_SUPPLEMENTzinc sulfate

1 zinc sulfate capsule for 15 weeks

1 corn starch capsule for 15 weeks

Sponsors

National Nutrition and Food Technology Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age of 18 to 45 years * Non-smoking * Body Mass Index (BMI) more than 30

Exclusion criteria

* Pregnancy, lactation or menopause in women * History of liver disease, kidney, thyroid, diabetes and other metabolic diseases * Use of drugs interfering with lipid profile, blood-thinning drugs, beta-blockers * Patients with immune deficiency * Use of zinc, calcium and iron supplement in the last 2 months * Use of weight loss medication or special diet * Following program to lose weight in recent 2 months * Recent surgery

Design outcomes

Primary

MeasureTime frame
weight15 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026